NEWS Immunoassay tests are commonly used to diagnose a whole host of disease medical conditions. admin December 6, 2023 No...
nano magnetic medical diagnostic technology.
levels of accuracy at the POC.
hand held devices using NanoTesla Dx.
precision than any existing POC
The NanoTesla Dx world class team is developing high sensitivity Point of Care (POC) hand held devices using NanoTesla Dx, a next-generation nano magnetic medical diagnostic technology. The patented NanoTesla Dx technology is expected to enable handheld, inexpensive devices to reach levels of accuracy at the POC currently available only in large, slow and expensive central laboratory analyzers.
NanoTesla Dx can detect assay test beads with far more precision than any existing technology, by recognising the aggregated magnetic signature of assay beads within a test strip. This new level of accuracy offers significant sensitivity advantages, by the detection of very low levels of analyte, paving the way for a next generation of high sensitivity assays at the POC. First development is a POC device to carry out high sensitivity cardiac biomarker assays, followed by the application of the NanoTesla Dx technology to numerous other immunoassay tests used to diagnose multiple indications.
NanoTesla Dx: Gold standard laboratory accuracy in a practitioner’s hand; at the scene of accident, in an ambulance, the ER or on the ward.
While other devices are limited to imperfect optical detection, NanoTesla detects magnetically to a whole new level of accuracy.
Immunoassay tests are commonly used to diagnose a whole host of disease medical conditions. In general the technology behind them relies on the manipulation of paramagnetic assay beads as analyte labels, as they are easy to manipulate magnetically, moving them through the assay process and concentrating them in a detection area.
NanoTesla Dx technology is capable of detecting extremely low levels magnetic field disturbance (nano-Tesla) caused by the assay beads.
Cardiac troponin is well documented as the preferred biomarker for diagnosis of myocardial infarction due to its high sensitivity and specificity for myocardial injury. Evidence continues to show that high sensitivity troponin is emerging as one of the most powerful prognostic biomarkers for the assessment of cardiovascular risk in the general population.
MIDS technology is capable of detecting extremely low levels magnetic field disturbance (nano-Tesla) caused by the assay beads…
NEWS Immunoassay tests are commonly used to diagnose a whole host of disease medical conditions. admin December 6, 2023 No...
NanoTesla Dx world class team is developing POC hand held devices using a next-generation nano magnetic medical diagnostic technology.
© 2023 NanoTesla Dx. All rights reserved.